Search

Your search keyword '"Bezgin, Gleb"' showing total 416 results

Search Constraints

Start Over You searched for: Author "Bezgin, Gleb" Remove constraint Author: "Bezgin, Gleb"
416 results on '"Bezgin, Gleb"'

Search Results

1. Modeling the influence of the hippocampal memory system on the oculomotor system

2. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

3. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

4. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

5. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

6. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

7. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging

8. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex

9. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

10. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

13. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging

14. Full-density multi-scale account of structure and dynamics of macaque visual cortex

15. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease.

17. Synaptic dysfunction, Tau pathology and Neurodegeneration

18. CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration

19. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

20. Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer’s disease continuum

21. Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum

22. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

23. Mapping the effects of functional and structural network reorganization on the tau‐cognition relationship in Alzheimer’s disease

24. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

25. Microglial activation interacts with amyloid‐β to drive longitudinal tau tangle accumulation and cognitive decline

26. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies

27. Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer’s disease

28. Hippocampal subfield volumes and memory performances: associations with stimulus modality and free recall or recognition

29. Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators

30. Microglial Activation Contributes to Neuropsychiatric Dysfunction in Alzheimer’s Disease

31. Employing transfer learning to optimize deep learning models for Alzheimer’s disease classification using two tau PET tracers

32. Synaptic dysfunction in the presence of tau tangles is not a strong predictor of atrophy

33. Plasma p‐tau231 and p‐tau217 provides information on tau tangle deposition in symptomatic Alzheimer’s disease individuals

34. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

35. Hippocampal subfield associations with memory depend on stimulus modality and retrieval mode

36. Translation of monosynaptic circuits underlying amygdala fMRI neurofeedback training

37. Stable long-range interhemispheric coordination is supported by direct anatomical projections

39. Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum

40. Transcriptomic signatures of Abeta- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer's disease pathophysiology

41. Plasma p‐tau231 and p‐tau217 inform on tau tangles aggregation in cognitively impaired individuals

43. Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET

44. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

45. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease

46. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden

49. Medial Temporal Tau Predicts Memory Decline in Cognitively Unimpaired Elderly (P5-6.011)

50. APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

Catalog

Books, media, physical & digital resources